Catalyst Wire Dossier Catalyst Wire Dossier

ChondroMimetic

· TiGenix n.v.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ChondroMimetic, covering 2011-09-20 to 2018-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Follow-Up Study Evaluating the Long Term Outcome of ChondroMimetic in the Treatment of Osteochondral Defects in the Knee

See pricing